Estrella Immunopharma, Inc.
ESLA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,627 | $1,317 | $421 | $917 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $397 | $164 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | -$397 | $0 | $523 | $724 |
| Total Curr. Assets | $2,024 | $1,481 | $944 | $1,641 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,500 | $1,500 | $1,500 | $1,500 |
| Total NC Assets | $1,500 | $1,500 | $1,500 | $1,500 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,524 | $2,981 | $2,444 | $3,141 |
| Liabilities | – | – | – | – |
| Payables | $6 | $8 | $14 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $4 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $385 | $9,063 | $4,275 | $2,983 |
| Total Curr. Liab. | $13,360 | $9,075 | $4,275 | $2,997 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $0 | $0 |
| Total Liabilities | $13,360 | $9,075 | $4,275 | $2,997 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $4 | $4 |
| Retained Earnings | -$36,378 | -$31,576 | -$26,032 | -$23,927 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$9,836 | -$6,095 | -$1,831 | $144 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,524 | $2,981 | $2,444 | $3,141 |
| Net Debt | -$1,627 | -$1,317 | -$421 | -$917 |